Cognitive impairment in progressive supranuclear palsy is associated with tau burden

Cognitive impairment is one of the core features of progressive supranuclear palsy. This study aimed to clarify the profile of cognitive impairment and its underlying pathology in progressive supranuclear palsy.

[1]  Stewart G. Armitage,et al.  An Analysis of Certain Psychological Tests Used for the Evaluation of Brain Injury , 2017 .

[2]  D. Dickson,et al.  Reply re: “Profile of cognitive impairment and underlying pathology in multiple system atrophy” , 2017, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Antonini,et al.  Cognitive impairment in multiple system atrophy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[4]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[5]  J. Morris,et al.  Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease , 2017, Neurology.

[6]  D. Dickson,et al.  Profile of cognitive impairment and underlying pathology in multiple system atrophy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[7]  W. Poewe,et al.  Brain structural profile of multiple system atrophy patients with cognitive impairment , 2017, Journal of Neural Transmission.

[8]  D. Dickson,et al.  Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[9]  D. Dickson,et al.  Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C , 2016, Movement disorders : official journal of the Movement Disorder Society.

[10]  D. Dickson,et al.  When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.

[11]  J. Cummings,et al.  Concordance of the Montreal cognitive assessment with standard neuropsychological measures , 2015, Alzheimer's & dementia.

[12]  Anthony J. Spychalla,et al.  Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy , 2014, The Journal of Neuroscience.

[13]  R. Kessels,et al.  Development and reliability of the Indonesian Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) , 2014 .

[14]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 2014, Seminars in Neurology.

[15]  D. Tulsky,et al.  Memory functioning in individuals with traumatic brain injury: An examination of the Wechsler Memory Scale–Fourth Edition (WMS–IV) , 2013, Journal of clinical and experimental neuropsychology.

[16]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[17]  D. Dickson,et al.  Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.

[18]  Y. Agid,et al.  Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. , 2010, Brain : a journal of neurology.

[19]  D. Dickson,et al.  Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. , 2008, Brain : a journal of neurology.

[20]  A. Lees,et al.  Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.

[21]  P. S. Mathuranath,et al.  Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA) , 2005, Neurocase.

[22]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[23]  D. Dickson,et al.  Microglial Activation Parallels System Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 2001, Journal of neuropathology and experimental neurology.

[24]  P. Green,et al.  Effort has a greater effect on test scores than severe brain injury in compensation claimants , 2001, Brain injury.

[25]  M. Rohling Generating a linear function for residual impairment for TBI: a comparison of the HRB and a flexible battery approach , 2000 .

[26]  R. Spitzer,et al.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.

[27]  K. Boone,et al.  Handbook of Normative Data for Neuropsychological Assessment , 1999 .

[28]  Jeffrey L. Cummings,et al.  Neuropsychiatric aspects of progressive supranuclear palsy , 1996, Neurology.

[29]  J. Hodges,et al.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy , 1996, Journal of Neurology.

[30]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[31]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[32]  L. Golbe,et al.  Psychiatric symptoms in progressive supranuclear palsy. , 1995, Psychosomatics.

[33]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[34]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[36]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Arie Pseudodementia. , 1983, British medical journal.

[38]  M. Albert,et al.  The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.

[39]  D. Watt,et al.  Frontal-Subcortical Dementias , 2012 .

[40]  D. Wechsler,et al.  Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV) , 2010 .

[41]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[42]  神田 信彦 Beck Depression Inventory-IIについての一考察 , 2004 .

[43]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.